17
53
Growth Score
0 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1025470
HaplnScience is a pharmaceutical company that focuses on anti-aging therapies that can reverse tissue and organ degeneration.
- Daekyung Kim: CSO
- Choi Hak-bae: CEOPast Role: JW Pharmaceuticals, EVP
About the Company
HaplnScience is a pharmaceutical company that focuses on anti-aging therapies that can reverse tissue and organ degeneration. The company contributes to the health and happiness of the elderly through the development of anti-aging therapy that can reverse tissue and organ degeneration. They developing new medicines with HAPLN1, a new protein that
can reverse tissue degeneration with strengthening the extracellular matrix.
HalpnScience was founded in 2018 and is headquartered in Seongnam-si, Gyeonggi-do, South Korea.
